Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Intellia Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 284
- −4 vs. Q2 2024
- Shares held
- 93.2M
- +12.8M (+15.9%) vs. Q2 2024
- Total value
- $1.92B
- +$114.9M (+6.4%) vs. Q2 2024
- New holders
- 43
- 112 more added
- Sold out
- 47
- 86 more reduced
3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −23,739−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −19,621−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −19,535−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −17,748−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −12,860−100.0% | Sold out |
| Natixis Advisors, L.P. | 0 | $0 | 0.00% | −12,249−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −10,818−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −10,467−100.0% | Sold out |
| Kraematon Investment Advisors, Inc | 0 | $0 | 0.00% | −9,815−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −6,534−100.0% | Sold out |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −3,856−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −3,143−100.0% | Sold out |
| Kelly Financial Services LLC | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,186−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −839−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Sunbelt Securities, Inc. | 0 | $0 | 0.00% | −570−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −322−100.0% | Sold out |
| Trust Co of Vermont | 0 | $0 | 0.00% | −216−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Stone House Investment Management, LLC | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Family Firm, Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Baldwin Brothers Inc | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| DiNuzzo Private Wealth, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Benjamin F. Edwards & Company, Inc. | – | – | – | – | Not filed |
| Emfo, LLC | – | – | – | – | Not filed |